| Charity Hospice Care, Inc. 500 Carson Plaza Drive Suite 222, Carson, CA, 90746 | |
| (310) 527-2962 |
News Archive
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
A South Dakota State University scientist's research shows an extract made from a food plant in the Brassica family was effective in alleviating signs of ulcerative colitis, an inflammatory bowel condition, in mice.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
› Verified 9 days ago
| Name | Charity Hospice Care, Inc. |
|---|---|
| Location | 500 Carson Plaza Drive Suite 222, Carson, California |
| Hospice ID | 551709 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 200 |
News Archive
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
A South Dakota State University scientist's research shows an extract made from a food plant in the Brassica family was effective in alleviating signs of ulcerative colitis, an inflammatory bowel condition, in mice.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
› Verified 9 days ago
| NPI Number | 1821379173 |
| Organization Name | Charity Hospice Care Inc. |
| Address | 500 E Carson Plaza Dr Carson, California, 90746 |
| Phone Number | (310)527-4339 |
News Archive
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
A South Dakota State University scientist's research shows an extract made from a food plant in the Brassica family was effective in alleviating signs of ulcerative colitis, an inflammatory bowel condition, in mice.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
› Verified 9 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 94.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 94.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 90.2 | 97.3 |
| Patients who got timely treatment for shortness of breath | 87.1 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 96.6 | 93.3 |
News Archive
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
A South Dakota State University scientist's research shows an extract made from a food plant in the Brassica family was effective in alleviating signs of ulcerative colitis, an inflammatory bowel condition, in mice.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
› Verified 9 days ago
| Home Health Aides | 2 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 2 |
| Physicians | 2 |
| Registered Nurses | 2 |
| Other Personnel | 1 |
| Total Employees | 12 |
|---|
News Archive
The Center for Medicine in the Public Interest (CMPI) today launched BigGovHealth.org, a new initiative to expose the consequences of greater government control in health care.
A new report projects that 5.2 million adults will not get health coverage next year because their states aren't expanding Medicaid under the health law. In Wisconsin, expanding the program becomes an issue in the gubernatorial race, while in North Carolina, county commissioners ask state officials to reconsider their decision not to expand and in Virginia, supporters of expansion outnumber opponents in a hearing.
A South Dakota State University scientist's research shows an extract made from a food plant in the Brassica family was effective in alleviating signs of ulcerative colitis, an inflammatory bowel condition, in mice.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
› Verified 9 days ago
| Charity Hospice Care, Inc. Location: 500 Carson Plaza Drive Suite 222, Carson, California, 90746 Phone: (310) 527-2962 |